Articles de revue et publications didactiques (2005 - 1999)

Physiopathologie et neuroprotection des lésions cérébrales périnatales

Publications

Equipe 1. Publications 2006 - (2005 - 2004) - (2003 - 2002) - (2001 - 2000) - (1999)
1. Publications originales

2006

1. Ramanantsoa N, Vaubourg V, Dauger S, Matrot B, Vardon G, Chettouh Z,Gaultier C, Goridis C and Gallego J. VentilatoryResponseto Hyperoxia in Newborn Mice Heterozygous for the Transcription Factor Phox2b. Am J.PhysiolRegulIntegr Comp Physiol 2006 in press.
    
2. Keller M, Simbruner G, Gorna A, Urbanek M, Griesmaier E, Sarkozy G,  Schwendimann L, Gressens P. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice. Pediatr.Res., 2006, sous presse.
    
3. Paris A, Mantz J, Toner PH,  Hein H, Brede M, Gressens P. Effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. AnesthAnalg, 2006, 102: 456-461.
    
4. Rousset CI, Chalon S, Cantagrel S, Bodard S, Andres C, Gressens P. Saliba E. Maternal exposure to LPS induces hypomyelination  in the internal capsule and programmed cell death in deep gray matter in newborn  rats. Pediatr.Res., 2006, sous presse.
    
5. Bemelmans AP, Husson I, Jaquet M, Mallet J, Kosofsky BE, Gressens P. Viral-mediated gene transfer of BDNF is neuroprotective in a mouse model of neonatal excitotoxic challenge. J. Neurosci. Res., 2006, 83 : 50-60.

2005

1. Bouslama M, Durand E, Van den Bergh O and Gallego J. Olfactory classical conditioning in newborn mice. Behav Brain Res 2005, 161: 102-106.
    
2. Durand E, Dauger S, Pattyn A, Gaultier C, Goridis C and Gallego J. Sleep-disordered breathing in  newborn mice heterozygous for the transcription factor Phox2b. Am J RespirCrit Care Med 2005, 172: 238-43.
    
3. Blattes E, Lockhart B, Lestage P, Schwendimann L, Gressens P, Fleury MB, Largeron M. Novel
   2-alkylamino-1,4-benzoxazine derivatives as potent neuroprotective agents: structure-activity relationship studies. J Med Chem 2005, 48 : 1282-1286.
    
4. Husson I, Rangon CM, Lelièvre  V, Bemelmans AP, Sachs P, Mallet J, Kosofsky BE, Gressens P. BDNF-induced white matter neuroprotection and stage-dependant neuronal survival following a neonatal excitotoxic challenge. Cereb. Cortex, 2005, 15:  250-261.
    
5. Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jegou S,  Janet T, Gressens P. VPAC2 receptors mediateVIP-induced neuroprotection againstneonatal excitotoxic brainlesions in mice. J. Pharmacol. Exp. Ther., 2005, 314: 745-752.
    
6. Sfaello  I, Baud O, Arzimanoglou A, Gressens P. Topiramate prevents excitotoxic  damage in the newborn rodent brain. Neurobiol. Dis., 2005, 20: 837-848.
    
7. Armstrong L, Abd El Moneim A, Aleck K, Aughton DJ, Baumann C, Braddock SR, Gillessen-Kaesbach G, Graham JM Jr, Grebe TA, Gripp KW, Hall BD, Hennekam R, Hunter A, Keppler-Noreuil K, Lacombe D, Lin AE, Ming JE, Kokitsu-Nakata NM, Nikkel SM, Philip N, Raas-Rothschild A, Sommer A, Verloes A, Walter C, Wieczorek, D, Williams MS, Zackai E, Allanson JE. Further delineation of Kabuki syndrome in 48 well-defined new individuals. Am J Med Genet A. 2005, 132: 265-72.
    
8. Baud O, Verney C, Evrard P, Gressens P. Injectable Dexamethasone administration enhances cortical GABAergic neurons maturation in a novel model of postnatal steroid therapy in mouse. Pediatr Res 2005, 57: 149-156.
    
9. Bremond-Gignac D, Crolla JA, Copin H, Guichet A, Bonneau D, Taine L, Lacombe, D, Baumann C, Benzacken B, Verloes A. Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion.Eur J Hum Genet. 2005 Jan 26; [Epub ahead of print
    
10. Matrot B, Durand E, Dauger S, Vardon G, Gaultier C, Gallego J. Automatic classification of activity and apneas using whole body plethysmography in newborn mice. J Appl Physiol 2005, 98: 365-370.
     
11. Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T. Control of human H9 cells proliferation by vasoactive intestinal peptide or peptide histidine methionine: implication of GTP-insensitive binding sites. J Neuroimmunol 2005, 158: 94-105.
     
12. Husson I, Rangon CM, Lelièvre V, Bemelmans AP, Sachs P, Mallet J, Kosofsky BE, Gressens P. BDNF-induced white matter neuroprotection and stage-dependant neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 2005, sous presse.
     
13. Mathijssen IB, Fryns JP, Devriendt K, Sznajer Y, Van Eygen M.  Iris heterochromia: a variable feature in Verloes-Koulischer-oral-acral syndrome. Am J Med Genet A. 2005;132:338-9
     
14. Mesplès B, Fontaine RH, Lelièvre V, Launay JM, Gressens P. Neuronal TGF-β₁ mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol Dis 2005, 18: 193-205.
     
15. Sfaello  I, Daire JL, Husson I, Kosofsky BE, Sebag G, Gressens P. Patterns of  excitotoxin-induced brain lesions in the newborn rabbit: A neuropathological and  MRI correlation. Dev. Neurosci., 2005, 27: 160-168.
     
16. Verloes A. Updated diagnostic criteria for CHARGE syndrome: A proposal. Am J Med Genet A. 2005; [Epub ahead of print]

2004

1. Dauger S, Durand E, Cohen G, Lagercrantz H, Changeux JP,  Gaultier C and Gallego J. Control of breathing in newborn mice lacking the  beta-2 nAChR subunit. Acta PhysiolScand 2004, 182: 205-12
    
2. Baud O, Daire JL, Dalmaz Y, Fontaine RH, Krueger RC, Sebag G, Evrard P, Gressens P, Verney C. Gestational hypoxia induces white matter damage in neonatal rats: a new model of periventricular leukomalacia. Brain Pathol, 2004, 14 : 1-10.
    
3. Baud O, Greene AE, Li J, Wang H, Volpe JJ, Rosenberg PA. Glutathione peroxidase-catalase cooperativity is required for restistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci, 2004, 24: 1540-1541.
    
4. Cazillis M, Bringuier AF, Delautier D, Buisine M, Bernuau D, Gespach C, Groyer A. Disruption of MKK4 signalling reveals its tumor-suppressor role in embryonic stem cells. Ongocene, 2004, 23: 4735-4744.
    
5. Cazillis M, Gonzalez BJ, Billardon C, Lombet A, Fraichard A, Samarut J, Gressens P, Vaudry H, Rostène W. VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells. Eur J Neurosci, 2004, 19: 798-808.
    
6. Dahmani S, Reynaud C, Tesnière A, Rouelle D, Desmont JM, Mantz J. Lidocaine increase phosphorylation of focal adhesion kinase in rat hippocampal slices. Eur J Pharmacol, 2004, 489: 55-58.
    
7. Dahmani S, Tesniere A, Rouelle D, Desmonts JM, Mantz J. Thiopental and isoflurane attenuate the decrease in hippocampal phosphorylated Focal Adhesion Kinase (pp125FAK) content induced by oxygen-glucose deprivation. Br J Anaesth 2004, 93: 270-274
    
8. Dahmani S, Tesniere A, Rouelle D, Toutant M, Desmonts JM, Mantz J. Effects of anesthetic agents on focal adhesion kinase (pp125FAK) tyrosine phosphorylation in rat hippocampal slices. Anesthesiology 2004, 101: 344-353.
    
9. Dollfus H, Verloes A.  Dysmorphology and the orbital region: a practical clinical approach. Surv Ophthalmol. 2004 Nov-Dec;49(6):547-61
    
10. Drobac, E, Durand, E, Laudenbach V, Mantz J, Gallego J. A simple method for short-term controlled anesthesia in newborn mice. Physiol Behav, 2004, 82: 79-83.
     
11. Durand E, Lofaso F, Dauger S, Vardon G, Gaultier C, Gallego J. Intermittent hypoxia induces transient arousal delay in newborn mice. J Appl Physiol. 2004 96:1216-22
     
12. Fayol L, Baud O, Monier A, Pellerin L, Magistretti P, Evrard P, Verney C. Immunocytochemical expression of monocarboylate transportes in the human virtual cortex at midgestation. Dev Brain Res, 2004, 148 : 69-76.
     
13. Genevieve D, Baumann C, Huber C, Faivre L, Sanlaville D, Bodemer C, Hadj-Rabia S, Assoumou A, Verloes A, Raqbi F, Munnich A, Cormier-Daire V.  A novel form of syndromic cutis laxa with facial dysmorphism, cleft palate, and mental retardation. J Med Genet. 2004 Jun;41(6):e77
     
14. Gerard-Blanluet M, Romana S, Munier C, Le Lorc'h M, Kanafani S, Sinico M, Touboul C, Levaillant JM, Haddad B, Lopez N, Lelong F, De Villemeur TB, Verloes, A, Borghi E.  Classical West "syndrome" phenotype with a subtelomeric 4p trisomy. Am J Med Genet A. 2004 15;130A:299-302.
     
15. Hennebert O, Marret S, Carmeliet P, Gresens P, Laquerriere A, Leroux P. Role of tissue-derived plasminogen activator (t-PA) in an excitotoxic mouse model of neonatal white matter lesions. J Neuropathol Exp Neurol, 2004, 63 : 53-63.
     
16. Husson I, Mesplès B, Medja F, Leroux P, Kosofsky B, Gressens P. Mehtylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties. Neurosci, 2004, 125: 163-170.
     
17. Keren B, Hadchouel A, Saba S, Sznajer Y, Bonneau D, Leheup B, Boute O, Gaillard D, Lacombe D, Layet V, Marlin S, Mortier G, Toutain A, Beylot C, Baumann C, Verloes A, Cave H; French Collaborative Noonan Study Group.  PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet. 2004 ;41:e117.
     
18. Lado-Abeal J, Dumitrescu AM, Liao XH, Cohen RN, Pohlenz J, Weiss RE, Lebrethon MC, Verloes A, Refetoff S.  A de novo Mutation in an already mutant nucleotide of the thyroid hormone receptor beta gene perpetuates resistance to thyroid hormone. J Clin Endocrinol Metab. 2004 Dec 14; [Epub ahead of print
     
19. Megarbane A, Daou L, Megarbane H, Cave H, Chouery E, Verloes A.  New autosomal recessive syndrome with short stature and facio-auriculo-thoracic malformations. Am J Med Genet. 2004 Aug 1;128A(4):414-7.
     
20. Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, Genevieve D, Hadj-Rabia S, Gaudy-Marqueste C, Smitt HS, Vabres P, Faivre L, Verloes A, Van Essen T, Flori E, Hennekam R, Beemer FA, Laurent N, Le Merrer M, Cau P, Levy N.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet. 2004;13:2493-503.
     
21. Nsegbe E, Wallen-Mackenzie A, Dauger S, Roux JC, Shvarev Y, Lagercrantz H, Perlmann T, Herlenius E. Congenital hypoventilation and impairedhypoxicresponse in Nurr1 mutantmice. J Physiol (Lond) 2004, 556:43-59.
     
22. Sahir N, Evrard P, Gressens P. Caffeine induces Sonic Hedgehog gene expression in cultured astrocytes and neurons. J Mol Neurosci, 2004, 24: 251-256.
     
23. Shibamura H, Olson JM, van Vlijmen-Van Keulen C, Buxbaum SG, Dudek DM, Tromp G, Ogata T, Skunca M, Sakalihasan N, Pals G, Limet R, MacKean GL, Defawe, O, Verloes A, Arthur C, Lossing AG, Burnett M, Sueda T, Kuivaniemi H.  Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13Circulation. 2004 May 4;109(17):2103-8.
     
24. Wen TC, Rogido M, Gressens P, Sola A. A reproducible experimental model of focal cerebral ischemia in the neonatal rat. Brain Res. Protoc., 2004, 13 : 76-83
     
25. Verloes A, Bitoun P, Heuskin A, Amrom D, van de Broeck H, Nikkel SM,Chudley AE, Prasad AN, Rusu C, Covic M, Toutain A, Moraine C, Parisi MA, Patton, M, Martin JJ, Van Thienen MN. Mobius sequence, Robin complex, and hypotonia: severe expression of brainstem disruption spectrum versus Carey-Fineman-Ziter syndrome. Am J Med Genet. 2004 Jun 15;127A(3):277-87.
     
26. Verloes A, Massin M, Fransolet AC, Misson JP.  Hypertrichosis, Fallot tetralogy, growth and developmental delay. Clin Dysmorphol. 2004 ;3:247-50
     
27. Verloes A, Raoul M, Genevieve D, Sznajer Y, Demarche M, Lombet J, Rigo V, Misson JP, Collignon L, Vanwijck F, Vanwijck R.  Bony syngnathia, vertebral segmentation defect, coloboma, microcephaly and mental retardation: confirmation of Dobrow syndrome and review of syndromal syngnathias. Clin Dysmorphol. 2004;13:205-11.